Havana, Dec. – Cuba and Russia have signed an agreement to establish the joint venture Sinergia Global Biopharmaceutical, aimed at the development, production, and commercialization of high-tech medicines, announced executives from Biocubafarma to Cubadebate.
The new entity represents the first of its kind established on the territory of the Russian Federation, marking a strategic step in bilateral cooperation in the biopharmaceutical sector.
The project aims to accelerate research and the availability of innovative drugs, with expected benefits for patients in both countries as well as regions such as Latin America and Eurasia.
The initial programs will focus on oncology, brain diseases, autoimmune conditions, and other chronic non-communicable diseases, according to representatives of the Cuban industry.
Biocubafarma executives stated that the parties are committed to ensuring that the results impact the health of the populations that require them.
The initiative reflects the continuity of the historical ties between the governments and peoples of Cuba and Russia and strengthens cooperation in a sector considered a high priority for both nations.
(Taken from Cubadebate)
